Celyad Oncology signs $40 million equity purchase agreement with Lincoln Park Capital
BRUSSELS: Celyad Oncology SA has entered into a committed equity purchase agreement for up to $40 million with Lincoln Park Capital Fund LLC, a Chicago-based institutional investor. Over the 24-month term of the Purchase Agreement, the Company will have the…